<VariationArchive VariationID="837072" VariationName="NM_003001.5(SDHC):c.77+2dup" VariationType="Duplication" Accession="VCV000837072" Version="11" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2020-04-15" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="850742" VariationID="837072">
      <GeneList>
        <Gene Symbol="SDHC" FullName="succinate dehydrogenase complex subunit C" GeneID="6391" HGNC_ID="HGNC:10682" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161314381" stop="161363206" display_start="161314381" display_stop="161363206" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161284165" stop="161334540" display_start="161284165" display_stop="161334540" Strand="+" />
          </Location>
          <OMIM>602413</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_003001.5(SDHC):c.77+2dup</Name>
      <CanonicalSPDI>NC_000001.11:161323671:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161323671" stop="161323672" display_start="161323671" display_stop="161323672" variantLength="1" positionVCF="161323671" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161293461" stop="161293462" display_start="161293461" display_stop="161293462" variantLength="1" positionVCF="161293461" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003001.3" sequenceAccession="NM_003001" sequenceVersion="3" change="c.77+2dupT">
            <Expression>NM_003001.3:c.77+2dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.161293462dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.161293462dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.161323672dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.161323672dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012767.1" sequenceAccession="NG_012767" sequenceVersion="1" change="g.14297dup">
            <Expression>NG_012767.1:g.14297dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407119.1" sequenceAccession="NM_001407119" sequenceVersion="1" change="c.-35+2dup">
            <Expression>NM_001407119.1:c.-35+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407120.1" sequenceAccession="NM_001407120" sequenceVersion="1" change="c.-153+2dup">
            <Expression>NM_001407120.1:c.-153+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407115.1" sequenceAccession="NM_001407115" sequenceVersion="1" change="c.77+2dup">
            <Expression>NM_001407115.1:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003001.5" sequenceAccession="NM_003001" sequenceVersion="5" change="c.77+2dup" MANESelect="true">
            <Expression>NM_003001.5:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035511.3" sequenceAccession="NM_001035511" sequenceVersion="3" change="c.77+2dup">
            <Expression>NM_001035511.3:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035512.3" sequenceAccession="NM_001035512" sequenceVersion="3" change="c.77+2dup">
            <Expression>NM_001035512.3:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278172.3" sequenceAccession="NM_001278172" sequenceVersion="3" change="c.77+2dup">
            <Expression>NM_001278172.3:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407118.1" sequenceAccession="NM_001407118" sequenceVersion="1" change="c.77+2dup">
            <Expression>NM_001407118.1:c.77+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407116.1" sequenceAccession="NM_001407116" sequenceVersion="1" change="c.21-4724dup">
            <Expression>NM_001407116.1:c.21-4724dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407121.1" sequenceAccession="NM_001407121" sequenceVersion="1" change="c.21-4724dup">
            <Expression>NM_001407121.1:c.21-4724dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407117.1" sequenceAccession="NM_001407117" sequenceVersion="1" change="c.21-4724dup">
            <Expression>NM_001407117.1:c.21-4724dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035513.3" sequenceAccession="NM_001035513" sequenceVersion="3" change="c.20+9247dup">
            <Expression>NM_001035513.3:c.20+9247dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_317" sequenceAccession="LRG_317">
            <Expression>LRG_317:g.14297dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_317t1" sequenceAccession="LRG_317t1">
            <Expression>LRG_317t1:c.77+2dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="766486676" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003001.5(SDHC):c.77+2dup AND multiple conditions" Accession="RCV001038332" Version="9">
        <ClassifiedConditionList TraitSetID="23697">
          <ClassifiedCondition DB="MedGen" ID="C0238198">Gastrointestinal stromal tumor</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1854336">Paragangliomas 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-21" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003001.5(SDHC):c.77+2dup AND Hereditary cancer-predisposing syndrome" Accession="RCV002400228" Version="3">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22517557</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23666964</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="23697" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5732" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 3</ElementValue>
                <XRef ID="Paragangliomas+3/5580" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011544" DB="MONDO" />
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SDHC-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (Paragangliomas 3)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomus tumors, familial, 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10545" />
                <XRef ID="10545" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2009">
                <ID Source="pmc">2668639</ID>
              </Citation>
              <Citation Type="review">
                <ID Source="PubMed">20816580</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Neuroendocrine and Adrenal Tumors, 2023</CitationText>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C1854336" DB="MedGen" />
              <XRef ID="MONDO:0011544" DB="MONDO" />
              <XRef Type="MIM" ID="605373" DB="OMIM" />
            </Trait>
            <Trait ID="2160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal Stromal Sarcoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal stromal tumor, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal stroma tumor</ElementValue>
                <XRef ID="HP:0100723" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gastrointestinal stromal tumor</ElementValue>
                <XRef ID="Gastrointestinal+Stromal+Tumors/2997" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011719" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GIST</ElementValue>
                <XRef Type="MIM" ID="606764" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KIT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8598" />
                <XRef ID="8598" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="UK NEQAS, 2012">
                <ID Source="PubMed">22685257</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gist.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastrointestinal Stromal Tumors, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, 2024</CitationText>
              </Citation>
              <XRef ID="44890" DB="Orphanet" />
              <XRef ID="C0238198" DB="MedGen" />
              <XRef ID="D046152" DB="MeSH" />
              <XRef ID="MONDO:0011719" DB="MONDO" />
              <XRef Type="MIM" ID="606764" DB="OMIM" />
              <XRef Type="primary" ID="HP:0100723" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2366974" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4820856|MedGen:C1854336;C0238198" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001201798" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23666964</ID>
          </Citation>
          <Comment>In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in individual(s) with head and neck paraganglioma (PMID: 23666964). This variant is present in population databases (rs766486676, ExAC 0.002%). This sequence change falls in intron 2 of the SDHC gene. It does not directly change the encoded amino acid sequence of the SDHC protein, but it affects a nucleotide within the consensus splice site of the intron.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.161293461_161293462insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1854336" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0238198" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5159117" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a193717|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002670524" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22517557</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23666964</ID>
          </Citation>
          <Comment>The c.77+2dupT intronic pathogenic mutation, results from a duplication of one nucleotide at position c.77+2 after intron 2 of the SDHC gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. This alteration has been reported in multiple individuals with a personal history consistent with hereditary paraganglioma-pheochromocytoma syndrome (PGL/PCC) (Buffet A et al. Horm Metab Res, 2012 May;44:359-66; Rattenberry E et al. J Clin Endocrinol Metab, 2013 Jul;98:E1248-56). Further, two other alterations impacting this canonical donor site (c.77+1G&gt;A, c.77+1G&gt;C) have been reported in individuals with a personal history consistent with hereditary paraganglioma-pheochromocytoma syndrome (PGL/PCC) (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003001.3:c.77+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2366974" TraitType="Disease" MappingType="XRef" MappingValue="C1854336" MappingRef="MedGen">
        <MedGen CUI="C1854336" Name="Paragangliomas 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2366974" TraitType="Disease" MappingType="XRef" MappingValue="C0238198" MappingRef="MedGen">
        <MedGen CUI="C0238198" Name="Gastrointestinal stromal tumor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5159117" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

